Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Marc Vasse and Tiffany Pascreau.
Marc Vasse
Connection Strength
2.921
Tiffany Pascreau
  1. The high frequency of anti-PF4/heparin antibodies in patients with COVID-19 is neither related to heparin treatment or to an increased incidence of thrombosis. Clin Chem Lab Med. 2021 10 26; 59(11):e405-e408.
    View in: PubMed
    Score: 0.954
  2. ADAMTS 13 deficiency is associated with abnormal distribution of von Willebrand factor multimers in patients with COVID-19. Thromb Res. 2021 08; 204:138-140.
    View in: PubMed
    Score: 0.928
  3. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome. Crit Care. 2021 05 06; 25(1):166.
    View in: PubMed
    Score: 0.236
  4. Spring is coming, where are the Respiratory Syncytial Virus and Influenza viruses? J Clin Virol. 2021 06; 139:104824.
    View in: PubMed
    Score: 0.235
  5. A low level of CD16pos monocytes in SARS-CoV-2 infected patients is a marker of severity. Clin Chem Lab Med. 2021 Jun 25; 59(7):1315-1322.
    View in: PubMed
    Score: 0.233
  6. Interest of the cellular population data analysis as an aid in the early diagnosis of SARS-CoV-2 infection. Int J Lab Hematol. 2021 Feb; 43(1):116-122.
    View in: PubMed
    Score: 0.225
  7. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis? Eur J Clin Microbiol Infect Dis. 2020 Oct; 39(10):1997-2000.
    View in: PubMed
    Score: 0.055
  8. SARS-CoV-2 RT-PCR: at least 2 viral targets are needed. Infect Dis (Lond). 2020 08; 52(8):583-584.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.